Return to search

Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock

Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40–50%. In refractory CS, active mechanical circulatory support devices including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are rapidly evolving. However, supporting evidence of VA-ECMO therapy in infarct-related CS is low. The current review aims to give an overview on the basics of VA-ECMO therapy, current evidence, ongoing trials, patient selection and potential complications.

Identiferoai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:85730
Date02 June 2023
CreatorsFreund, Anne, Desch, Steffen, Pöss, Janine, Sulimov, Dmitry, Sandri, Marcus, Majunke, Nicolas, Thiele, Holger
PublisherMDPI
Source SetsHochschulschriftenserver (HSSS) der SLUB Dresden
LanguageEnglish
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text
Rightsinfo:eu-repo/semantics/openAccess
Relation2077-0383, 1256

Page generated in 0.0018 seconds